NewGenIvf Group (NIVF) terminated a binding term sheet with European Wellness Investment Holdings for a reverse merger.
European Wellness didn't meet the deadline to provide draft audited financial statements for 2023 and 2024, NewGenIvf said Monday in a statement.
The companies agreed to the binding term sheet on Dec. 11 with European Wellness planning to acquire almost 62% of NewGen. The $452 million transaction valued NewGenIvf stock at $3.20 a share.
European Wellness didn't immediately respond to a request for comment from MT Newswires.
Shares of NewGenIvf fell 34% in recent Monday trading.
Price: 0.61, Change: -0.33, Percent Change: -33.80
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。